Literature DB >> 11206995

Psychosocial aspects in palliative care--communicating with the patient and family.

J Hockley1.   

Abstract

The dynamics surrounding the patient and family facing a death as the 'unit of care' is discussed. Aspects of communication, openness within the family, especially concerning children and teenagers, and factors that enable a family to function under the stress of a loved one's terminal illness are explored. The use of a genogram in palliative care to help to piece together the family dynamics and available support is fundamental to the care for the whole family.

Entities:  

Mesh:

Year:  2000        PMID: 11206995     DOI: 10.1080/02841860050215864

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  A Family-Centered Model for Sharing Genetic Risk.

Authors:  Mary B Daly
Journal:  J Law Med Ethics       Date:  2015       Impact factor: 1.718

2.  Setting up a palliative care clinic within a radiotherapy department: a model for developing countries.

Authors:  M Bansal; Firuza D Patel; Bidhu K Mohanti; S C Sharma
Journal:  Support Care Cancer       Date:  2003-05-03       Impact factor: 3.603

3.  Ward social workers' views of what facilitates or hinders collaboration with specialist palliative care team social workers: A grounded theory.

Authors:  Janice Firn; Nancy Preston; Catherine Walshe
Journal:  BMC Palliat Care       Date:  2017-07-14       Impact factor: 3.234

4.  The Infant Feeding Genogram: a tool for exploring family infant feeding history and identifying support needs.

Authors:  K L Darwent; R J McInnes; V Swanson
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-19       Impact factor: 3.007

Review 5.  Communication and support from health-care professionals to families, with dependent children, following the diagnosis of parental life-limiting illness: A systematic review.

Authors:  Rachel Fearnley; Jason W Boland
Journal:  Palliat Med       Date:  2016-07-11       Impact factor: 4.762

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.